Title

Familial Hypercholesterolemia

Authoring Organization

National Lipid Association

Publication Month/Year

June 1, 2011

Last Updated Month/Year

December 20, 2024

Document Type

Guideline

External Publication Status

Published

Country of Publication

US

Document Objectives

 This document provides recommendations for the screening, diagnosis and treatment of Familial Hypercholesterolemia in pediatric and adult patients developed by the National Lipid Association Expert Panel on Familial Hypercholesterolemia

Target Patient Population

Pediatric and adult patients with Familial Hypercholesterolemia

Inclusion Criteria

Male, Female, Adolescent, Adult, Child, Older adult

Health Care Settings

Ambulatory, Outpatient

Intended Users

Nurse, nurse practitioner, physician, physician assistant

Scope

Diagnosis, Assessment and screening, Treatment, Management

Diseases/Conditions (MeSH)

D050171 - Dyslipidemias, D006950 - Hyperlipidemia, Familial Combined, D006720 - Homozygote, D006579 - Heterozygote

Keywords

dyslipidemia, screening, familial hypercholesterolemia

Source Citation

Goldberg AC, Hopkins PN, Toth PP, Ballantyne CM, Rader DJ, Robinson JG, Daniels SR, Gidding SS, de Ferranti SD, Ito MK, McGowan MP, Moriarty PM, Cromwell WC, Ross JL, Ziajka PE. Familial hypercholesterolemia: screening, diagnosis and management of pediatric and adult patients. Clinical guidance from the National Lipid Association Expert Panel on Familial Hypercholesterolemia. J Clin Lipidol. 2011;5:133-140. PMID: 21600517.

Juxtapid (lomitapide) capsules prescribing information. Cambridge, MA: Aegerion Pharmaceuticals. December 2012.

Kynamro (mipomersen sodium) injection prescribing information. Cambridge, MA: Genzyme Corporation. 2013.